Breaking through emerging market barriers

11/18/2013 |

A growing middle class in Brazil, Russia, India, China and other emerging markets offers an opportunity for life sciences companies to expand, but barriers have hindered some drugmakers' expansion efforts, writes Hussain Moorajis, global managing director at Accenture. Drugmakers need "an effective multifaceted strategy to get established, maintain competitiveness and drive profit," Moorajis writes, identifying six main challenges to expansion in emerging markets and offering a four-part approach to gaining a competitive edge.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
Minneapolis, MN